Steven Cohen Amphastar Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 38,817 shares of AMPH stock, worth $1.71 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,817
Previous 235,836
83.54%
Holding current value
$1.71 Million
Previous $9.43 Million
80.04%
% of portfolio
0.01%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding AMPH
# of Institutions
287Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$262 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$120 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$94.1 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$85.8 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$71.2 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...